Recruiting
Phase 2

TIL & IL-2

Sponsor:

Karam Khaddour, MD, MS

Code:

NCT07288073

Conditions

Cutaneous Squamous Cell Carcinoma

Merkel Cell Carcinoma

Metastatic Cutaneous Squamous Cell Carcinoma

Skin Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LN-145

Cyclophosphamide

Fludarabine

Interleukin-2

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-11. This information was provided to ClinicalTrials.gov by Karam Khaddour, MD, MS on 2026-02-13.